erythromycin propionate-n-acetylcysteinate and Injuries, Spinal Cord

erythromycin propionate-n-acetylcysteinate has been researched along with Injuries, Spinal Cord in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnett, SC; Boomkamp, SD; Houslay, MD; McGrath, MA	1

Other Studies

1 other study(ies) available for erythromycin propionate-n-acetylcysteinate and Injuries, Spinal Cord

Article	Year
Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model. British journal of pharmacology, 2014, Volume: 171, Issue:9 Topics: Acetylcysteine; Animals; Animals, Newborn; Cells, Cultured; Dose-Response Relationship, Drug; Erythromycin; Nerve Fibers, Myelinated; Neurites; Phosphodiesterase 4 Inhibitors; Protein Binding; Rats; Rats, Sprague-Dawley; Rolipram; Spinal Cord Injuries	2014

Article

Year

Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model.

British journal of pharmacology, 2014, Volume: 171, Issue:9

Topics: Acetylcysteine; Animals; Animals, Newborn; Cells, Cultured; Dose-Response Relationship, Drug; Erythromycin; Nerve Fibers, Myelinated; Neurites; Phosphodiesterase 4 Inhibitors; Protein Binding; Rats; Rats, Sprague-Dawley; Rolipram; Spinal Cord Injuries

2014